Related Experiment Video
Updated: Jun 29, 2026
07:24
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
APOE genotyping: comparison of three methods.
B H Rihn1, S Berrahmoune, S Berahmoune
1EA 3442, Faculté de Pharmacie, 5 rue Albert Lebrun, BP 403, 54001, Nancy Cedex, France. Bertrand.Rihn@pharma.uhp-nancy.fr
Clinical and Experimental Medicine
|October 10, 2008
Summary
A new, rapid fluorescent resonance energy transfer (FRET) method accurately genotypes Apolipoprotein E (APOE) polymorphisms, crucial for predicting cardiovascular and Alzheimer
Area of Science:
- Genetics and Molecular Biology
- Biotechnology
- Clinical Diagnostics
Background:
- Apolipoprotein E (APOE) gene polymorphism is a significant risk factor for cardiovascular diseases and Alzheimer's disease.
- Accurate genotyping of APOE alleles is essential for predictive diagnostics and personalized medicine approaches.
- Existing genotyping methods may lack the speed, specificity, or reliability required for high-throughput analysis.
Purpose of the Study:
- To develop and validate a rapid, reliable, and specific method for APOE genotyping using fluorescent resonance energy transfer (FRET).
- To simultaneously detect common APOE polymorphisms (epsilon2, epsilon3, epsilon4) and identify all six possible genotypes in a single assay.
- To assess the efficiency and accuracy of the FRET-based method compared to traditional techniques like RFLP and sequencing.
Main Methods:
- Development of a FRET-based assay utilizing a LightTyper device and dedicated probes for high-throughput APOE genotyping.
- The assay involves three key steps: DNA extraction from blood, PCR amplification of the APOE fragment, and FRET melting curve analysis.
- Validation of the FRET method using 75 blood samples, with comparative analysis against Restriction Fragment Length Polymorphism (RFLP) and DNA sequencing.
Main Results:
- The FRET assay successfully identified all six common APOE genotypes with high throughput and specificity.
- Genotype distribution observed: 72.0% epsilon3/epsilon3, 14.7% epsilon3/epsilon4, 6.6% epsilon2/epsilon3, 4.0% epsilon2/epsilon4, and 1.3% for epsilon2/epsilon2 and epsilon4/epsilon4 homozygotes.
- A novel polymorphism at codon 158 was detected by FRET and confirmed by sequencing, highlighting limitations of RFLP in genotyping accuracy.
Conclusions:
- The developed FRET method provides a rapid, reliable, and specific approach for high-throughput APOE genotyping.
- This assay facilitates the simultaneous detection of major APOE polymorphisms, aiding in the prediction of associated disease risks.
- The study underscores the superior sensitivity of FRET and sequencing over RFLP for accurate genetic polymorphism detection.
